2026. Integrated Computational Design, Green Synthesis, and Characterization of 3,4-Dihydropyrimidine Derivatives Targeting Enoyl-Acyl Carrier Protein Reductase for Tuberculosis Treatment. International Journal of Research in Pharmaceutical Sciences and Technology. 9, 3 (Aug. 2026). DOI:https://doi.org/10.33974/bnb32f45.